CVS Health (CVS)
(Delayed Data from NYSE)
$58.40 USD
-0.02 (-0.03%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $58.42 +0.02 (0.03%) 4:42 PM ET
4-Sell of 5 4
A Value D Growth D Momentum C VGM
Price, Consensus and EPS Surprise
CVS 58.40 -0.02(-0.03%)
Will CVS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CVS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CVS
Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?
CVS Health (CVS) Rises Higher Than Market: Key Facts
CVS: What are Zacks experts saying now?
Zacks Private Portfolio Services
CVS Stock Gains From Its Birth Control Prescribing Service Launch
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
Why Is CVS Health (CVS) Up 0.4% Since Last Earnings Report?
Other News for CVS
CVS Health announces quarterly dividend
Wells Fargo’s ‘Value Equity List’ – Stocks with potential that trade at a discount
CVS Health declares $0.665 dividend
Interesting CVS Put And Call Options For May 2025
5 Incredible Healthcare High-Yield Blue-Chip Bargain Buys For 2025